Startups made easy. Sorted.

Hero Optimise Novora
2 min read
Expert reviewed

Creating a doctor in your pocket with Norvana.

Published:  Aug 19, 2025
Contents
  • Key takeaways
  • Anthony Rose
    Co-Founder and CEO
    Anthony Rose

    Co-Founder and CEO

    The healthcare system is stretched. Doctor shortages, long wait times and patients stuck in queues instead of getting help.

    That’s why serial tech founder Jostein Svendsen started Norvana, a smart health app powered by AI. It connects with your wearables to give you instant, personalized health advice, helping you take action before problems start. Think of it as your very own health assistant, right in your pocket. And soon, it could automate up to 80% of everyday care.

    SeedLegals Co-Founder and CEO Anthony Rose caught up with Jostein to find out why Norvana is starting with weight loss, how the tech works and what’s next as they line up launch partners across the US, UK and Malta.

    Key takeaways

    The problem with traditional healthcare 

    • Healthcare systems worldwide are under strain, with too few professionals and growing patient backlogs.
    • Tech adoption in health is years behind sectors like FinTech, leaving massive opportunity for automation.
    • Everyday health issues like sleep, stress, diet and weight aren’t being proactively managed with personalized support.

    Norvana’s AI-powered solution 

    • Norvana acts as a personal wellness assistant, using AI to deliver nutrition advice, exercise coaching, mental health check-ins and more.
    • It combines data from wearables, health records and specialist AI (including vision-based models for fitness and food).
    • The goal: Let doctors focus on the hard stuff and let AI handle the rest.

    Traction and growth

    • Norvana is in the pre-launch stage with confirmed partners in the UK ready to roll it out to 70,000+ private patients.
    • A US launch partner is also lined up, with access to 250,000 users, starting with a weight loss programme powered by AI and GLP-1 medications.
    • Governments like Malta are already eyeing clinical trials, with potential to roll it out nationwide if successful.
    SeedLegals newsletter

    Connect with fascinating founders

    Sign up to our newsletter and get exclusive updates and invites delivered directly to your inbox.

    Newsletter Sidebar blog ad
    Stay ahead with the SeedLegals newsletter
    Get event invites and hot-off-the-press content straight to your inbox

    Start your journey with us